17 July 2024 in Toxicology Mechanisms and Methods
Chronic exposure to manganese compounds leads to accumulation of the manganese in the basal ganglia and hippocampus. High levels of manganese in these structures lead to oxidative stress, neuroinflammation, imbalance of brain neurotransmitters, and hyperactivation of calpains mediating neurotoxicity and causing motor and cognitive impairment. The purpose of this work was to study the effect of excess manganese chloride intake on rats' spatial memory and on dopamine-β-hydroxylase (DβH) activity under conditions of calpain activity suppression. Rats were divided into 3 groups of 10 animals each. Group 1 received MnCl2 (30 days, 5 mg/kg/day, intranasally), group 2 received MnCl2 (30 days, 5 mg/kg/day, intranasally) and calpain inhibitor Cast (184-210) (30 days, 5 µg/kg/day, intranasally), and group 3 received sterile saline (30 days in a volume of 20 μl, intranasally). The spatial working memory was assessed using Morris water maze test. DβH activity was determined by HPLC. We have shown that in response to excessive intake of MnCl2, there was a development of cognitive impairments in rats, which was accompanied by a decrease in DβH activity in the hippocampus. The severity of cognitive impairment was reduced by inhibiting the activity of m-calpain. The protective effect of calpain inhibitors was achieved not through an effect on DβH activity. Thus, the development of therapeutic regimens for the treatment of manganism using dopaminomimetics and/or by inhibiting calpains, must be performed taking into account the manganese-induced decrease of DβH activity and the inability to influence this process with calpain inhibitors.
6 January 2026 in Journal of Neuroscience Research
25 May 2025 in European Journal of Neuroscience
19 March 2025 in Toxicology Reports
MKMarina Nikolaevna Karpenko
Marina Nikolaevna Karpenko
Manganese-induced damage to the serotonergic system was considered to be one of the causes of the development of affective disorders, such as depression and anxiety. However, in the literature, only a few studies could be found on the mechanisms that described the influence of excess manganese levels on the serotonergic system of the central nervous system (CNS). Therefore, it was an important medical and biological task to study the mechanisms underlying the development of affective disorders. This work focused on studying the main mechanisms of the development of affective disorders in male rats under conditions of chronic intranasal administration of manganese chloride (MnCl2) at a dose of 5 mg/kg for 34 consecutive days. We showed that chronic intranasal administration of MnCl2 led to the development of increased anxiety and depression in rats, the cause of which was a decrease in serotonin concentration in the striatum and an increase in serotonin concentration in the hippocampus, caused by changes in the expression of tryptophan hydroxylase (tph-2) and aromatic L-amino acid decarboxylase (aadc) mRNA.
29 October 2024 in Medical academic journal
МАМайстренко Виктория Александровна
Майстренко Виктория Александровна
BACKGROUND: Nowadays, due to the increasing number of infectious and inflammatory diseases, the problem of the use of antibacterial drugs becomes especially important. As a result of the action of toxins, inflammatory processes can affect the central nervous system with the subsequent development of neuroinflammation. Activation of neuroinflammation leads to dysregulation of many physiological functions. These negative appearances can be observed even after a long period. It is known that doxycycline is a tetracycline-type antibiotic, which is able to penetrate the blood-brain barrier and has anti-inflammatory activity. AIM: The aim of this study was to investigate the nature of delayed physiological changes in rats against the background of administration of the antibacterial drug doxycycline in the LPS-induced model of neuroinflammation. MATERIALS AND METHODS: Four groups of Wistar rats, 10 males in each group, were used in the experiment. The first group was injected once intraperitoneally with physiological solution, the second group — with lipopolysaccharide (1 mg/kg). Animals of the third and fourth groups received intragastrically doxycycline solution (25 mg/kg) daily for two weeks. On the 15th day of the experiment, rats from the fourth group were injected with lipopolysaccharide (1 mg/kg). Body weight of animals, mass coefficients of immunocompetent organs, as well as behaviour and motor activity of rats in the “Open Field” test were evaluated at several time points. RESULTS: It was shown that systemic injection of lipopolysaccharide led to an increase in the mass coefficients of spleen, kidneys and adrenal glands compared to the group of animals receiving doxycycline beforehand. These changes were noted 48 h and 2 months after the injection of endotoxin. In the “Open Field” test, animals that were injected with doxycycline and lipopolysaccharide showed no violations of motor activity and research behavior, unlike the group that received only lipopolysaccharide. CONCLUSIONS: It can be assumed that the physiological effects of doxycycline in the lipopolysaccharide-induced model of neuroinflammation revealed at early and late terms are not limited to the antibacterial effect of the drug and are mediated by anti-inflammatory and potential neuroprotective effects on the central nervous system.
24 December 2024 in Medical academic journal
ОАОбухова Дарья Алексеевна
BACKGROUND: Autism spectrum disorder and attention deficit hyperactivity disorder are complex disorders of nervous development. Both diseases are diagnosed in childhood and are often comorbital. Rats with a knockout of the dopamine transporter gene (DAT) exhibit symptoms characteristic of attention deficit hyperactivity disorder. Prenatal treatment with valproic acid is used to model autism spectrum disorder. Dysfunction of the dopaminergic system may be one of the causes of attention deficit hyperactivity disorder and autism spectrum disorder. However the neurochemical mechanisms underlying dysfunction of the dopaminergic system and contributing to the pathogenesis of attention deficit hyperactivity disorder require further studies. AIM: Therefore, the aim of the work was to investigate the expression levels of dopamine catabolism genes in heterozygous rats with a knockout of the DAT encoding gene and induced valproate syndrome. MATERIALS AND METHODS: The work was performed on 32 rats aged 40 days (adolescence). In total, 4 groups of baby rats were formed in the study: DAT:Salt, DAT:VPA, WT:VPA and WT:Salt, where DAT/WT is the presence or absence of a genetic factor (DAT is a heterozygote for knockout of the SLC6A3 gene, WT is the wild type), VPA/Salt is the presence or absence of a toxic factor (induced valproate syndrome). RESULTS: The expression of mRNA monoamine oxidase A and monoamine oxidase B in the midbrain was reduced in the groups DAT:Sat, DAT:VPA, WT:VPA compared to the control group WT:Salt. The expression mRNA of catechol-O-methyltransferase mRNA in the midbrain of rats DAT:Salt is significantly higher than in the control group WT:Salt, however, the treatment with valproic acid leads to a decrease in catechol-O-methyltransferase expression in heterozygous rats by knocking out the SLC6A3 gene. No changes in the expression of monoamine oxidase A, monoamine oxidase B, catechol-O-methyltransferase mRNA were observed in the prefrontal cortex and striatum. CONCLUSIONS: The development of valproate syndrome and/or reduce dopamine reuptake leads to a decrease in the levels of monoamine oxidase A and monoamine oxidase B mRNA in the rat midbrain. Prenatal exposure to valproic acid led to a decrease in the level of catechol-O-methyltransferase mRNA in the midbrain of heterozygous rats by knockout of the DAT gene.